Real-world data platform based in California Health Atropos announced that healthcare data analytics company Arcadia has joined its healthcare product portfolio, providing Arcadia supplier customers and life sciences users with access to Atropos offerings.
Atropos Health delivers innovations in AI, evidence generation, analytics augmentation, and data assessment to help physicians access real-world evidence to guide clinical decisions and research.
The company’s clinical informatics services, known as Green Button, provide publication-quality observational study reports based on a user’s clinical questions, and its Geneva OS offering is an operating system for evidence fast healthcare data across a vast network of real-world data.
Arcadia, based in Washington, DC, is a managed services organization that provides providers with tools for network administration, payment management, process improvement around visit access and referrals, and monitoring of pre-authorizations.
Through this partnership, Arcadia joins Atropos’ Evidence Network, giving its users access to Atropos’ portfolio of applications to support clinical decision-making in value-based care.
Atropos life sciences users can also use Arcadia’s longitudinal research dataset to conduct real-world evidence studies.
“A critical component of value-based care is optimizing clinical decision-making where existing published evidence is insufficient,” Dr. Brigham Hyde, CEO and co-founder of Atropos Health, said in a statement.
“This collaboration further enables healthcare providers to rapidly generate new peer-reviewed evidence to make data-driven decisions on optimal clinical guidelines, care pathways, and best interventions for success in value-based care and other quality initiatives.
THE BIGGEST TREND
In December, HealthGuidean AI-enabled, value-based care provider for healthcare systems, announced that it had acquired Arcadia’s value-based care division and managed services organization.
The company also signed an agreement with Arcadia to use its data analytics platform to power the acquired offerings, which will work with its predictive and generative AI.
In April, Arcadia scored $125 million in funding three years after receiving $29.5 million investment in growth stocks.
Last year, Atropos Health raised $14 million in Series A funding.
The company announced numerous partnerships last year, including a collaboration with Janssen Research & Development, a Johnson & Johnson company, to accelerate clinical development through real-world data analysis.
Atropos has also partnered with clinical analytics and patient record summarization company KAID Health, a data-sharing technology startup. Datavant and health data company SEQSTER.
